HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR CHANGING ALLOWABLE CONCENTRATIONS OF CETRIMONIUM CHLORIDE

This article was originally published in The Rose Sheet

Executive Summary

CIR CHANGING ALLOWABLE CONCENTRATIONS OF CETRIMONIUM CHLORIDE, cetrimonium bromide and steartrimonium chloride in leave-on cosmetic products to .25% from .1% after taking a second look at data on the ingredient. The Cosmetic Ingredient Review (CIR) expert panel, at its Sept. 12-13 meeting in Washington, D.C., changed the status of the report on the group of quaternary ammonium salts from final back to tentative. Like all tentative reports, it will now be subject to a 90-day public comment period. The ingredients continue to be designated as safe as used in rinse-off products. They are used in a total of 205 preparations, 102 of which are hair conditioner products, according to FDA data from 1994.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000869

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel